Assuntos
Picada de Aranha/patologia , Adolescente , Vesícula/etiologia , Vesícula/patologia , Humanos , MasculinoRESUMO
This is a prospective study of 145 patients whose fetuses presented in the posterior position. Only 31 percent of these delivered spontaneously. Nine were delivered by caesarean section. The remainder were delivered by forceps or ventouse extraction. The management of the posterior presentation is discussed.
Assuntos
Apresentação no Trabalho de Parto , Adulto , Cesárea , Parto Obstétrico , Feminino , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Masculino , Forceps Obstétrico , Paridade , Gravidez , Estudos Prospectivos , Rotação , Vácuo-ExtraçãoAssuntos
Adulto , Humanos , Masculino , Osteoma , Neoplasias dos Seios Paranasais , Seio Esfenoidal , Neoplasias Maxilares , Seio FrontalRESUMO
Fifty women with vaginal Candida albicans infection were given Pimafucin (natamycin) vaginal tablets, two nightly for 10 days. At two weeks there was a 76 percent cure rate which was maintained at four weeks.
Assuntos
Candidíase Vulvovaginal/tratamento farmacológico , Natamicina/uso terapêutico , Adolescente , Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Natamicina/administração & dosagem , ComprimidosRESUMO
Flagyl (metronidazole) was evaluated in the prophylaxis and treatment of patients undergoing gynaecological surgery. One hundred patients were studied: 50 of these patients received prophylactic metronidazole and 50 received matching placebos. Eight percent of metronidazole treated patients developed wound infections which was less than half the number of untreated patients, 18 percent of whom developed wound infection. No anaerobic infections were seen in Flagyl treated patients whereas four (8 percent) were seen in placebo patients.
Assuntos
Doenças dos Genitais Femininos/cirurgia , Metronidazol/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Anaerobiose , Infecções Bacterianas/prevenção & controle , Ensaios Clínicos como Assunto , Método Duplo-Cego , Feminino , Febre/prevenção & controle , HumanosRESUMO
Cancer of the ovary is the leading cause of death from gynaecological cancer. Forty-six cases are reported to re-emphasise certain features. These include the short history and the high mortality rate regardless of what treatment is used. Whereas improvement has occurred in the treatment of cancer of the corpus and the cervix, there has been no improvement over two decades in cancer of the ovary. The moral of this tale, is to advise your women folk to avoid cancer of the ovary.
Assuntos
Neoplasias Ovarianas/diagnóstico , Adolescente , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Nova Zelândia , Neoplasias Ovarianas/epidemiologia , Fatores de TempoAssuntos
Menopausa , Sintomas Afetivos/epidemiologia , Atrofia/tratamento farmacológico , Climatério/efeitos dos fármacos , Estrogênios/uso terapêutico , Feminino , Humanos , Menopausa/efeitos dos fármacos , Distúrbios Menstruais/epidemiologia , Pessoa de Meia-Idade , Vaginite/tratamento farmacológicoRESUMO
A new potent fungicidal preparation, miconazole nitrate 2 percent (Gynodaktarin) was used in 40 patients, both pregnant, with vulvovaginal candidiasis. It was as effective in pregnant as in non-pregnant patients. Retreatment in three cases of recurrence was successful. There were no side effects reported, and the drug was found to be safe for pregnant patients and their offspring.
